New treatment option for endometrial cancer shows promise in phase II trial

The latest trial of a new antibody drug that delivers potent chemotherapy directly to cancer cells for patients with advanced or recurrent endometrial cancer moves ahead to be studied further in a phase III trial.

Annual General Meeting resolves dividend distribution of EUR 0.88 per share – Biotech Investments

EQS-News: Dermapharm Holding SE / Key word(s): AGM/EGM Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 0.88 per share 27.06.2024 / 18:15

June 28, 2024

Pharmalittle: We’re reading about MDMA for PTSD, a CRISPR treatment for blindness, and more

Top of the morning to you, and a fine one it is. There is nothing like being greeted with clear blue skies and cool breezes

May 7, 2024

Shared community spaces in rural communities may promote healthy aging among older, non-white adults

Millions of Americans over the age of 65 lack access to the social and emotional support they need for healthy aging, according to the Centers

June 20, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.